For these reasons, we assumed that the patterns and effects of BRCA1 or BRCA2 pathogenic variants related to breast or ovarian cancer in Korean are different than those of other populations (not only non-Europeans but also other Asians). This evidence concerns the gene BRCA2 and ovarian cancer.